The acute ischemic stroke diagnosis market is poised for substantial growth over the forecast period, driven by the increasing prevalence of stroke cases, growing demand for rapid diagnostic solutions, and continuous advancements in medical imaging technologies. Healthcare providers are increasingly investing in advanced diagnostic platforms to improve early detection and support timely...

7 federal approvals for vascularized 3D bioprinted tissues in early 2026 As 2026 begins, the global regenerative medicine landscape is pivoting toward full-scale clinical integration, driven by new FDA and EMA frameworks for bio-ink standardization. Healthcare systems in North America and Western Europe are now moving past simple scaffold structures to functional, vascularized tissue...